The ‘rigorous’ team at Herbert Smith Freehills provides a ’customer-centric and solutions-oriented approach’ to investment banks, international corporations, Chinese state-owned enterprises (SOEs) and government- owned entities across a broad swathe of capital market linked products. Under the expert leadership of Matt Emsley, the team has particularly strong visibility within the biotech/healthcare and TMT sectors, and continues to pick up a significant volume of 18A listings. Praised for his ‘extremely keen insight and deep understanding of business’, Jeremy Shen excels in handling IPOs and follow-on offerings and is able to ’provide constructive and far-sighted opinions’.
Testimonials
Collated independently by Legal 500 research team.
- 'The rigorous team has a customer-centric and solutions-oriented approach.'
- 'Matt Emsley proactively participates in all major discussion and shares valuable experience and insights.'
Key clients
- China International Capital Corporation
- CITIC Securities
Work highlights
- Advised CITIC Securities, Citigroup and Goldman Sachs as joint sponsors of Onewo Inc.'s listing on the Main Board of the Hong Kong Stock Exchange.
- Advised CICC and CMB International as joint sponsors and underwriters of Lygend Resources & Technology Co.’s mainboard listing on the Stock Exchange of Hong Kong.